NCT00471419View on ClinicalTrials.gov

Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Dry Eye
Interventions
DRUG

Rimexolone

Trial Locations (1)

44115

Cleveland, Cleveland

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00471419 - Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye | Biotech Hunter | Biotech Hunter